Plus Therapeutics, Inc.
PSTV
$0.59
$0.00-0.31%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -59.69% | -43.82% | -130.36% | 2.54% | 15.03% |
| Total Depreciation and Amortization | -31.58% | -9.17% | -1.12% | -0.16% | -21.36% |
| Total Amortization of Deferred Charges | -100.00% | -100.00% | -97.14% | -89.47% | -79.17% |
| Total Other Non-Cash Items | 581.33% | 1,720.85% | 1,315.32% | -289.38% | -320.94% |
| Change in Net Operating Assets | -195.22% | -226.28% | 353.75% | 388.71% | 621.73% |
| Cash from Operations | -40.14% | -69.58% | -5.55% | 17.87% | 15.00% |
| Capital Expenditure | 72.88% | 79.77% | -5.83% | 8.75% | 28.05% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 107.55% | 74.93% | 66.05% | -- | -3,552.99% |
| Cash from Investing | 106.81% | 75.84% | 55.74% | -2,469.38% | -3,168.99% |
| Total Debt Issued | 13.55% | 13.55% | -- | -- | -- |
| Total Debt Repaid | -59.05% | -45.73% | -558.52% | -148.51% | -173.51% |
| Issuance of Common Stock | 376.59% | 76.56% | 395.94% | 32.26% | 25.24% |
| Repurchase of Common Stock | 100.00% | 91.00% | 91.00% | -232.54% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -3,125.68% | 55.47% | 100.00% | 100.00% | 45.79% |
| Cash from Financing | 386.18% | 85.88% | 790.07% | 79.59% | 38.91% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 223.34% | 55.22% | 170.92% | 11.37% | -5.65% |